Verify the efficacy of renal artery stenting to define the predictors of ischemic constriction via pressure gradient

Verify the efficacy of renal artery stenting to define the predictors of ischemic constriction via pressure gradient - VERDICT trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010109

Enrollment

300

Registered

2013-02-25

Start date

2013-02-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension and/or renal dysfunction due to atherosclerotic renal artery stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The atherosclerotic renal artery stenosis(ARAS) patients with 1: more than 145 or over mmHg systolic blood pressure at any time,or 135 mmHg or over in 24-hourABPM average systolic blood pressure And or / 2: CKD patients eGFR<60ml/min/1.73m2 (over CKD stage 3) ARAS is defined with more than RAR3.5 and PSV219cm/sec in duplexrenal artery echo

Exclusion criteria

Exclusion criteria: The patients of end stage renal dysfunction on hemodialysis Fibromuscular Dysplasia

Design outcomes

Primary

Measure	Time frame
Predictor of therapeutic effect of the treatment group showed a variation in response of hypertension and/or renal function	—

Countries

Japan

Contacts

Public ContactKaori Shimogama

VERDICT trial secretariat VERDICT trial secretariat

verdict@j-et.jp093-967-8680

Outcome results